Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.
Press Enter β΅ to start review
Explore by Goal
"Two possibilities exist: either we are alone in the Universe or we are not. Both are equally terrifying."
- Arthur C. Clarke
Quick Explanation
Copied
BGPT Paper Review
This Nature Reviews Cancer article synthesizes how 2-oxoglutarate-dependent dioxygenases (2OGDDs) couple oxygen, iron, 2OG, and oncometabolites to shape cancer metabolism and epigenetics, with mechanistic emphasis on EGLN (PHDs), FIH1, TETs, and KDMs (and how fumarate/succinate/R-2HG/S-2HG perturb them). Evidence strengths vary because the review repeatedly highlights known assay-dependent differences in kinetic parameters and challenges of translating in vitro Km values to in vivo physiology.
Paper:
Long Explanation
2-Oxoglutarate-dependent dioxygenases (2OGDDs) in cancer β visual, skeptical review
Oncometabolites inhibit/alter 2OGDDs, reshaping epigenetics and signaling
Big uncertainty
In vitro Km/IC50 values may not map cleanly to in vivo compartmentalized metabolite levels
Kinetic βoxygen sensitivityβ snapshot (2OGDD O2 Km; values explicitly present in the provided excerpt)
Lower O2 Km β higher oxygen affinity β relatively active under hypoxia (as discussed in the articleβs framework). Values shown are only those stated in the provided excerpt of Table 2; many other entries in the full table are not present in your input.
Source values for FIH1 (0.5 Β΅M), EGLN1 (0.05 Β΅M), EGLN2 (0.05 Β΅M), EGLN3 (0.1 Β΅M), and KDM6A (8β10 Β΅M shown as 8β10 in excerpt) come from the provided Table 2 kinetic section inside the target review.
The qualitative progression (moderate hypoxia inhibiting oxygen-sensitive EGLN/HIFΞ± hydroxylation; severe hypoxia causing broader 2OGDD inhibition with succinate and S-2HG accumulation) is explicitly described in the reviewβs βHypoxaemiaβ and βDysregulation of 2OGDD activity by hypoxiaβ sections/figures.
Oncometabolite β 2OGDD perturbation map (as described in the review)
This is a schematic based strictly on statements in the provided article text: fumarate/succinate/R-2HG/S-2HG are described as competitive inhibitors or functional modulators of subsets of 2OGDDs, with best-validated examples including TET2 for R-2HG and HIF/EGLN regulation for oxygen-sensitive dioxygenases. The review also notes that R-2HG can potentiate EGLN activity rather than simply inhibit it.
Fumarate/succinate are described as structurally similar to 2OG and able to act as competitive inhibitors of 2OGDDs, while R-2HG is described as an oncometabolite produced by mutant IDH that inhibits 2OGDD targets including the best-validated target TET2, and S-2HG is described as inhibiting EGLNs and TET2 in the hypoxiaβS-2HG immune loop.
Mechanistic core (what the review claims is most βcausalβ)
1) Reaction chemistry enables signal integration
The review emphasizes that 2OGDDs share a common mechanism requiring dioxygen (O2), divalent iron (Fe2+), and 2-oxoglutarate; catalysis hydroxylates substrates and yields succinate and CO2.
2) Oxygen affinity differences can create βselective inhibitionβ
The article frames hypoxia as a driver of selective 2OGDD repression: enzymes with higher O2 Km are inhibited first, producing HIFΞ± stabilization (EGLN pathway) and shifting downstream gene expression.
The review argues that mutations in FH/SDH/IDH can generate oncometabolites (fumarate, succinate, and R-2HG) that inhibit or modulate 2OGDDs, linking metabolic rewiring to epigenetic dysregulation.
Skeptical critique: where the reviewβs synthesis is strongest vs weakest
Strongest elements (best-supported causal links)
Shared chemistry + coupled co-substrate availability is consistently grounded in enzyme mechanism descriptions (Fe2+/2OG/O2) and in the reviewβs emphasis on oxygen sensitivity differences among 2OGDDs.
Best-validated R-2HG β TET2 link (AML context) is presented with converging biochemical + cellular + genetic evidence within the reviewβs narrative (even while noting R-2HG is a weak inhibitor in vitro and context matters).
Highest-impact uncertainties / blind spots
Translation of in vitro kinetic parameters to in vivo compartments: the review explicitly warns that metabolite compartmentalization (mitochondrial sequestration), rapid turnover, and difficulties measuring intracellular 2OG complicate direct inference of in vivo sensitivity from in vitro Km.
Assay-dependence of O2 Km and IC50: the review highlights conflicting O2 Km measurements across studies and explains that technical factorsβlike substrate length and assay contextβcan shift measured oxygen affinity, citing EGLN peptide-length effects.
Context-dependent tumor suppressor vs oncogene roles: the review states that some 2OGDDs can switch roles by cellular context; it explicitly calls out the unclear mechanisms and the possibility of paralogue redundancy/compensation complicating dependency interpretations from single-gene perturbations.
Key 2OGDD subclasses highlighted & what the review claims they do
The table below is strictly limited to subclass-level roles and mechanistic couplers explicitly stated in the provided paper text excerpt (not a full enumeration of all proteins from the Box 1 list).
2OGDD subclass (examples)
Primary biological function (as described)
Coupler(s) emphasized
EGLN (PHD1-3)
Oxygen sensors regulating HIFΞ± hydroxylation β HIF degradation vs stabilization
O2/2OGDD regulator limiting HIF transcriptional activity via asparaginyl hydroxylation
Intermediate O2 affinity; off-HIF substrate pool noted
TET1/2/3
DNA hydroxylases driving 5mC β 5hmC β further oxidized forms
2OGDD substrate sensitivity; oncometabolites (R-2HG, and hypoxia-linked S-2HG via TET inhibition) discussed
KDM family (JmjC demethylases)
Histone lysine demethylases linking oxygen/2OGDD activity to chromatin state
O2 Km variability and inhibitor sensitivity to fumarate/succinate/S-2HG emphasized
Subclass function/coupler statements are derived from the target reviewβs abstract and section summaries in the provided text (EGLN/HIFΞ± oxygen sensing; FIH1 HIF transcriptional regulation; TET DNA hydroxylases; KDM histone demethylases).
Author reviews (bespoke BGPT links)
Click an author to open BGPTβs author-focused review pages.
Feedback:
Updated: April 14, 2026
BGPT Paper Review
Study Novelty
70%
As a Nature Reviews Cancer article, it is primarily integrative rather than methodologically novel; its βnoveltyβ mainly lies in synthesizing how co-substrate availability (O2/Fe2+/2OG) and oncometabolites converge on 2OGDD subsets in cancer, while explicitly foregrounding assay-translation uncertainties and context-dependent functional directionality across KDMs/TETs.
Scientific Quality
80%
High scientific quality for a review: it repeatedly grounds claims in mechanistic enzyme chemistry and explicitly flags known limitations (Km/IC50 assay context, in vivo metabolite measurement difficulties, and context-dependent tumor-suppressor vs oncogenic roles). Major reproducibility constraint is inherent to reviews: it compiles evidence rather than generating new datasets, and it relies on heterogeneous primary-study methods for kinetic parameters.
Study Generality
80%
The core framework (2OGDD chemistry + co-substrate sensing + oncometabolite competition) generalizes across multiple cancer-relevant epigenetic and hypoxia pathways, but the detailed mechanistic claims become enzyme- and context-specific (so generality is strong at the conceptual level, weaker at the level of specific targets).
Study Usefulness
90%
Highly useful as a structured mechanistic map for researchers investigating oxygenβmetabolismβepigenetics coupling: it links specific cancer mutations to oncometabolites, and those to particular 2OGDD families/substrates, while explicitly cautioning against overinterpreting assay-derived parameters.
Study Reproducibility
30%
As a literature review, it does not generate new experimental results or provide machine-executable datasets; reproducibility depends on re-running and independently validating each summarized primary studyβs measurements (e.g., kinetic parameters) under appropriate assay conditions, which the review itself indicates vary.
Explanatory Depth
90%
The article provides deep mechanistic explanation: conserved reaction chemistry; oxygen/iron/2OG co-substrate dependencies; oxygen-affinity stratification; oncometabolite competitive/functional modulation; and multiple examples showing how the same enzyme family can behave differently depending on context and microenvironment.
Extract O2 Km and IC50 values visible in the provided Table 2 excerpt, rank enzymes by oxygen sensitivity and oncometabolite inhibitor potency, and render heatmaps to highlight assay-context uncertainties.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
Strongman to retire: βR-2HG inhibition of TET2 is the only necessary driver of all IDH-mutant epigenetic phenotypes across all tumor types.β The review itself notes that some IDH-mutant solid tumor contexts show no evidence of TET inhibition/5hmC loss, implying additional or alternative targets beyond TET2.
Strongman to retire: βIn vitro oxygen Km values are universally applicable in vivo.β The review explicitly cautions that assay context (substrate length, missing accessory factors/post-translational modifications) can shift oxygen sensitivity measurements and that intracellular metabolite quantification is difficult; it even discusses inconsistencies in O2 Km for certain enzymes.
Quick Explanation
Long Explanation
Top Data Sources
ExportMCP
Keep Exploring
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Explore by Goal
Ask a Follow-Up
Key Insight
